EP Patent

EP0250374A1 — Therapeutic system for controlled release of drugs

Assigned to Recordati SA · Expires 1987-12-23 · 38y expired

What this patent protects

A new modular delivery system is described, which is able to release the vehicled active ingredient at controlled rate and for a predetermined period of time. The new system is characterized by: 1. Dosage units obtained by compression comprising natural and/or synthetic, …

USPTO Abstract

A new modular delivery system is described, which is able to release the vehicled active ingredient at controlled rate and for a predetermined period of time. The new system is characterized by: 1. Dosage units obtained by compression comprising natural and/or synthetic, hydrophilic, biocompatible polymers, capable to swell on contact with water or aqueous fluids thus providing a swelling pressure, containing a therapeutically active dose of drug or fractions thereof, 2. A polymeric barrier coated on said units, which will break because of units volume increase after their contact with water, and controlling the fluids entrance within the system and, therefore, the core swelling. The active ingredient release is almost complete, and it may occur according to zero-order kinetics without insoluble residues of appreciable extent. A process for preparing said system is also described.

Drugs covered by this patent

Patent Metadata

Patent number
EP0250374A1
Jurisdiction
EP
Classification
Expires
1987-12-23
Drug substance claim
No
Drug product claim
No
Assignee
Recordati SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.